Korea Q2 Roundup: Hanmi Dispute Simmers, Emerging Obesity Focus

Mixed Results For Top Firms

 
• By Jung Won Shin
second quarter
mixed second quarter results for Korean pharma industry • Source: Shutterstock

More from Earnings

More from Business